Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Vitamin K deficiency and hepatocellular carcinoma.

Piquet MA, Hourmand-Ollivier I, Dao T.

JAMA. 2004 Dec 1;292(21):2580-1; author reply 2581. No abstract available.

PMID:
15572713
2.

Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.

Habu D, Shiomi S, Tamori A, Takeda T, Tanaka T, Kubo S, Nishiguchi S.

JAMA. 2004 Jul 21;292(3):358-61.

PMID:
15265851
3.

Effect of vitamin K2 on the development of hepatocellular carcinoma in type C cirrhosis.

Kojima K, Tamano M, Akima T, Hashimoto T, Kuniyoshi T, Maeda C, Majima Y, Kusano K, Murohisa T, Iijima M, Hiraishi H.

Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1264-7.

PMID:
21410069
4.

[Screening of hepatocellular carcinoma in patients with liver cirrhosis].

Pateron D, Ganne N, Beaugrand M.

Ann Chir. 1993;47(3):203-5. Review. French. No abstract available.

PMID:
7687419
5.

[What is the value of systematic screening of hepatocellular carcinomas in patients with liver cirrhosis?].

Pateron D.

Gastroenterol Clin Biol. 1992;16(11):908-9. French. No abstract available.

PMID:
1336468
6.

Pleiotropic actions of vitamin K: protector of bone health and beyond?

Kaneki M, Hosoi T, Ouchi Y, Orimo H.

Nutrition. 2006 Jul-Aug;22(7-8):845-52. Review.

PMID:
16815498
7.

[Prevention of hepatocellular carcinogenesis by interferon].

Ikeda K.

Nihon Rinsho. 2001 Oct;59 Suppl 6:755-63. Review. Japanese. No abstract available.

PMID:
11762051
8.

[Sho-saiko-to].

Oka H.

Nihon Rinsho. 2001 Oct;59 Suppl 6:774-8. Review. Japanese. No abstract available.

PMID:
11762055
9.

Screening of hepatocellular carcinoma in French patients.

Durand F, Buffet C, Pelletier G, Hagege H, Ink O, Etienne JP.

Dig Dis Sci. 1995 Mar;40(3):706-7. No abstract available.

PMID:
7895568
10.

Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge.

Poon RT.

Hepatology. 2011 Sep 2;54(3):757-9. doi: 10.1002/hep.24569. No abstract available.

PMID:
21793027
11.

Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma.

Hessheimer AJ, Forner A, Varela M, Bruix J.

Eur J Gastroenterol Hepatol. 2010 Oct;22(10):1239-44. doi: 10.1097/MEG.0b013e32833aa19b.

PMID:
20505515
12.

Coffee, liver enzymes, cirrhosis and liver cancer.

La Vecchia C.

J Hepatol. 2005 Apr;42(4):444-6. Epub 2005 Jan 21. Review. No abstract available.

PMID:
15763323
13.

Surveillance of the patients at high risk for developing hepatocellular carcinoma in Europe--between guidelines and reality.

Săndulescu L, Săftoiu A.

Ultraschall Med. 2013 Oct;34(5):483-4. No abstract available.

PMID:
24278973
14.

Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.

Zhong YD, Yang YF.

Hepatology. 2008 Oct;48(4):1348; author reply 1348. doi: 10.1002/hep.22492. No abstract available.

PMID:
18792394
15.

Re: Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.

Chen TH, Chiu SY.

Hepatology. 2008 Oct;48(4):1348-9. doi: 10.1002/hep.22530. No abstract available.

PMID:
18792397
16.

Vitamin D and K signaling pathways in hepatocellular carcinoma.

Louka ML, Fawzy AM, Naiem AM, Elseknedy MF, Abdelhalim AE, Abdelghany MA.

Gene. 2017 Sep 20;629:108-116. doi: 10.1016/j.gene.2017.07.074. Epub 2017 Jul 29. Review.

PMID:
28764978
17.

[Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].

Yoshida H, Omata M.

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):463-6. Review. Japanese. No abstract available.

PMID:
15359842
18.

[Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].

Nishiguchi S, Kubo S, Shiomi S.

Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):600-4. Review. Japanese. No abstract available.

PMID:
15359868
19.

Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence.

Siegel AB, El-Serag HB.

Expert Rev Gastroenterol Hepatol. 2013 Aug;7(6):493-5. doi: 10.1586/17474124.2013.814884. No abstract available.

20.

[Epidemiology, prevention, screening and diagnosis of hepatocellular carcinoma].

Trinchet JC, Alperovitch A, Bedossa P, Degos F, Hainaut P, Beers BV.

Bull Cancer. 2009 Jan;96(1):35-43. doi: 10.1684/bdc.2009.0791. Review. French.

Supplemental Content

Support Center